Intel is reportedly preparing a more aggressive push for its smartphone processor architecture, as demand apparently has been rather limited at this time and vendors apparently believe that the company isn't able to compete with ARM at this time.
According to Digitimes, Medfield is currently available in the Xolo 900 phone in India, in the San Diego phone that is sold by Orange across Europe, as well as the Lenovo K800 in China. ZTE will add a device for Chinese market in the second half of this year and Motorola is expected to follow suit over the next few months.
Despite Intel's aggressive approach to drive Medfield into the market, there have been only limited shipments of Intel-based high-end and maisntream smartphones, Digitimes said, and phone vendors are not expecting this situation to change anytime soon. They anticipate that 22 nm and 14 nm version of the SoC may do much better than the current 32 nm Medfield product.
While Intel claims that Medfield is much faster than competing ARM products, it will be an uphill battle to gain footing in a market that has been dominated by ARM products, and in a market that is characterized by existing business relations between ARM processor vendors and handset makers. However, it may be rather common sense that Intel has not leveraged its manufacturing superiority enough to pitch Medfield to phone makers. It may, in fact, take two more processor generations until Intel can establish credibility and vendor connections to be able to succeed.